Federica Liotti


University of Naples "Federico II", Department of molecular medicine and biotechnology
CNR/IEOS Istitute of Sperimental Edocrinology and Oncology "G.Salvatore"




1: Collina F, La Sala L, Liotti F, Prevete N, La Mantia E, Chiofalo MG, Aquino G,
Arenare L, Cantile M, Liguori G, Di Gennaro F, Pezzullo L, Losito NS, Vecchio G,
Botti G, Melillo RM, Franco R. AXL Is a Novel Predictive Factor and Therapeutic
Target for Radioactive Iodine Refractory Thyroid Cancer. Cancers (Basel). 2019
Jun 7;11(6). pii: E785. doi: 10.3390/cancers11060785. PubMed PMID: 31181609;
PubMed Central PMCID: PMC6628138.

2: Liotti F, Prevete N, Vecchio G, Melillo RM. Recent advances in understanding
immune phenotypes of thyroid carcinomas: prognostication and emerging therapies.
F1000Res. 2019 Feb 28;8. pii: F1000 Faculty Rev-227. doi:
10.12688/f1000research.16677.1. eCollection 2019. Review. PubMed PMID: 30854191;
PubMed Central PMCID: PMC6396838.

3: Prevete N, Liotti F, Amoresano A, Pucci P, de Paulis A, Melillo RM. New
perspectives in cancer: Modulation of lipid metabolism and inflammation
resolution. Pharmacol Res. 2018 Feb;128:80-87. doi: 10.1016/j.phrs.2017.09.024.
Epub 2017 Oct 3. Review. PubMed PMID: 28986132.

4: Prevete N, Liotti F, Illiano A, Amoresano A, Pucci P, de Paulis A, Melillo RM.
Formyl peptide receptor 1 suppresses gastric cancer angiogenesis and growth by
exploiting inflammation resolution pathways. Oncoimmunology. 2017 Feb
21;6(4):e1293213. doi: 10.1080/2162402X.2017.1293213. eCollection 2017. PubMed
PMID: 28507800; PubMed Central PMCID: PMC5414878.

5: Liotti F, De Pizzol M, Allegretti M, Prevete N, Melillo RM. Multiple
anti-tumor effects of Reparixin on thyroid cancer. Oncotarget. 2017 May
30;8(22):35946-35961. doi: 10.18632/oncotarget.16412. PubMed PMID: 28415590;
PubMed Central PMCID: PMC5482629.

6: Moretti S, Menicali E, Nucci N, Voce P, Colella R, Melillo RM, Liotti F,
Morelli S, Fallarino F, Macchiarulo A, Santoro M, Avenia N, Puxeddu E. Signal
Transducer and Activator of Transcription 1 Plays a Pivotal Role in RET/PTC3
Oncogene-induced Expression of Indoleamine 2,3-Dioxygenase 1. J Biol Chem. 2017
Feb 3;292(5):1785-1797. doi: 10.1074/jbc.M116.745448. Epub 2016 Dec 19. PubMed
PMID: 27994058; PubMed Central PMCID: PMC5290952.

7: Liotti F, Collina F, Pone E, La Sala L, Franco R, Prevete N, Melillo RM.
Interleukin-8, but not the Related Chemokine CXCL1, Sustains an Autocrine Circuit
Necessary for the Properties and Functions of Thyroid Cancer Stem Cells. Stem
Cells. 2017 Jan;35(1):135-146. doi: 10.1002/stem.2492. Epub 2016 Sep 21. PubMed
PMID: 27577959.

8: Prevete N, Liotti F, Marone G, Melillo RM, de Paulis A. Formyl peptide
receptors at the interface of inflammation, angiogenesis and tumor growth.
Pharmacol Res. 2015 Dec;102:184-91. doi: 10.1016/j.phrs.2015.09.017. Epub 2015
Oct 20. Review. PubMed PMID: 26466865.

9: Visciano C, Prevete N, Liotti F, Marone G. Tumor-Associated Mast Cells in
Thyroid Cancer. Int J Endocrinol. 2015;2015:705169. doi: 10.1155/2015/705169.
Epub 2015 Aug 26. Review. PubMed PMID: 26379707; PubMed Central PMCID:

10: Martinelli E, Martini G, Cardone C, Troiani T, Liguori G, Vitagliano D,
Napolitano S, Morgillo F, Rinaldi B, Melillo RM, Liotti F, Nappi A, Bianco R,
Berrino L, Ciuffreda LP, Ciardiello D, Iaffaioli V, Botti G, Ferraiolo F,
Ciardiello F. AXL is an oncotarget in human colorectal cancer. Oncotarget. 2015
Sep 15;6(27):23281-96. PubMed PMID: 25966280; PubMed Central PMCID: PMC4695118.

11: Visciano C, Liotti F, Prevete N, Cali' G, Franco R, Collina F, de Paulis A,
Marone G, Santoro M, Melillo RM. Mast cells induce epithelial-to-mesenchymal
transition and stem cell features in human thyroid cancer cells through an
IL-8-Akt-Slug pathway. Oncogene. 2015 Oct 1;34(40):5175-86. doi:
10.1038/onc.2014.441. Epub 2015 Jan 26. PubMed PMID: 25619830.

12: Melillo RM, Guarino V, Avilla E, Galdiero MR, Liotti F, Prevete N, Rossi FW,
Basolo F, Ugolini C, de Paulis A, Santoro M, Marone G. Mast cells have a
protumorigenic role in human thyroid cancer. Oncogene. 2010 Nov
25;29(47):6203-15. doi: 10.1038/onc.2010.348. Epub 2010 Aug 23. PubMed PMID:

13: Avilla E, Guarino V, Visciano C, Liotti F, Svelto M, Krishnamoorthy G, Franco
R, Melillo RM. Activation of TYRO3/AXL tyrosine kinase receptors in thyroid
cancer. Cancer Res. 2011 Mar 1;71(5):1792-804. doi:
10.1158/0008-5472.CAN-10-2186. Epub 2011 Feb 22. PubMed PMID: 21343401.

14: Liotti F, Visciano C, Melillo RM. Inflammation in thyroid oncogenesis. Am J
Cancer Res. 2012;2(3):286-97. Epub 2012 Apr 21. PubMed PMID: 22679559; PubMed
Central PMCID: PMC3365810.